Skip to main content
. Author manuscript; available in PMC: 2009 Dec 10.
Published in final edited form as: Neuroscience. 2008 Oct 1;157(4):895–907. doi: 10.1016/j.neuroscience.2008.09.038

Table 5.

Table 5A: Relative IL-6 mRNA expression in various sites after ipo casein injection
Leukocyt es Air pouch cells Liver Spleen Brain Hypothalamus Hippocampus Pituitary
ipo Vehicle ND ND ND ND ND ND ND ND
ipo Casein 4h ND *1.9±1.4 (×10−3) ND ND ND ND ND ND
ipo Casein 8h ND *2.0±0.3 (×10−3) ND ND ND ND ND ND
ipo LPS 6h ND *1.4±0.2 (×10−3) ND ND ND ND ND ND
Table 5B: IL-6 protein expression in various sites after ipo casein injection
Plasma (pg/ml) Airpouch lavage (pg/ml) Brain (pg/1mg protein) Hypothalamus (pg/1mg protein) Hippocampus (pg/1mg protein)
ipo Vehicle ND 36±11 2.7±0.5 ND ND
ipo Casein 4h *64±14 *6625±554 3.5±1.0 ND ND
ipo Casein 8h *87.5±16 *6500±736 3.1±0.8 ND ND
ipo LPS 6h *246±51 *4253±565 3.6±0.7 ND ND

IL-6 mRNA (A, IL-6/G3PDH) and protein (B) levels are shown. Values are means ± SEM (n=4).

Asterisk indicates significant difference (p<0.05) between vehicle-injected and inflammatory agents-injected animals. ND. Not Detectable